Alnylam Pharmaceuticals
ALNY
ALNY
495 hedge funds and large institutions have $17.2B invested in Alnylam Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 203 increasing their positions, 150 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 494 → 495 (+1)
2.83% less ownership
Funds ownership: 93.91% → 91.08% (-2.8%)
24% less capital invested
Capital invested by funds: $22.6B → $17.2B (-$5.41B)
Holders
495
Holding in Top 10
8
Calls
$461M
Puts
$304M
Top Buyers
| 1 | +$143M | |
| 2 | +$124M | |
| 3 | +$75.3M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$47.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$43M |
Top Sellers
| 1 | -$506M | |
| 2 | -$314M | |
| 3 | -$189M | |
| 4 |
Morgan Stanley
New York
|
-$140M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$121M |